Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
MacroGenics
MGNX
$257M
| $3.38M | ﹤0.01% |
504,066
+41,031
| +9% | +$225K |
|
3452
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
| $3.38M | ﹤0.01% |
74,276
+28,142
| +61% | +$1.27M |
|
3453
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.97B
| $3.38M | ﹤0.01% |
33,531
+6,682
| +25% | +$667K |
|
3454
Xtrackers MSCI USA ESG Leaders Equity ETF
USSG
$590M
| $3.38M | ﹤0.01% |
96,990
+47,088
| +94% | +$1.64M |
|
|
JRO
3455
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $3.38M | ﹤0.01% |
432,590
| – | – |
|
3456
U-Haul Holding Co
UHAL
$14.6B
| $3.38M | ﹤0.01% |
56,125
-181,625
| -76% | -$10.4M |
|
3457
Banc of California
BANC
$2.97B
| $3.37M | ﹤0.01% |
211,464
-202,132
| -49% | -$3.3M |
|
3458
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
| $3.36M | ﹤0.01% |
18,708
-34,288
| -65% | -$6.21M |
|
3459
Montauk Renewables
MNTK
$255M
| $3.36M | ﹤0.01% |
304,504
+98,491
| +48% | +$1.32M |
|
3460
MYR Group
MYRG
$5.25B
| $3.35M | ﹤0.01% |
36,412
-73,169
| -67% | -$6.64M |
|
|
FMIV
3461
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
| $3.35M | ﹤0.01% |
333,837
+3
| +0% | +$30 |
|
3462
AdvanSix
ASIX
$444M
| $3.35M | ﹤0.01% |
88,052
+23,690
| +37% | +$888K |
|
3463
BRC Group Holdings
RILY
$289M
| $3.34M | ﹤0.01% |
97,660
-164,944
| -63% | -$6.91M |
|
3464
AnaptysBio
ANAB
$1.68B
| $3.33M | ﹤0.01% |
107,575
+11,487
| +12% | +$324K |
|
3465
Conduent
CNDT
$264M
| $3.32M | ﹤0.01% |
820,196
-455,228
| -36% | -$1.74M |
|
3466
PUT
LyondellBasell Industries
LYB
$19.2B
| $3.32M | ﹤0.01% |
40,000
+10,000
| +33% | +$819K |
|
3467
PUT
Intuitive Surgical
ISRG
$134B
| $3.32M | ﹤0.01% |
+12,500
| New | +$3.05M |
|
3468
Agilysys
AGYS
$3.06B
| $3.31M | ﹤0.01% |
41,858
+7,643
| +22% | +$487K |
|
|
FTEV
3469
DELISTED
FinTech Evolution Acquisition Group
FTEV
| $3.31M | ﹤0.01% |
327,411
| – | – |
|
|
UCTT
3470
Ultra Clean Holdings
UCTT
$3.95B
| $3.3M | ﹤0.01% |
99,666
-13,968
| -12% | -$445K |
|
3471
CALL
Baidu
BIDU
$37.2B
| $3.29M | ﹤0.01% |
28,800
-8,400
| -23% | -$857K |
|
|
HA
3472
DELISTED
Hawaiian Holdings, Inc.
HA
| $3.29M | ﹤0.01% |
320,979
-51,579
| -14% | -$689K |
|
3473
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.25B
| $3.29M | ﹤0.01% |
37,968
+16,076
| +73% | +$1.43M |
|
|
AYX
3474
CALL
DELISTED
Alteryx Inc
AYX
| $3.29M | ﹤0.01% |
+64,900
| New | +$3.1M |
|
|
ACCD
3475
DELISTED
Accolade Inc
ACCD
| $3.29M | ﹤0.01% |
421,854
+22,236
| +6% | +$212K |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.